Drug Trial News

RSS
Pharmalink raises SEK 35 million to further advance Nefecon and Busulipo

Pharmalink raises SEK 35 million to further advance Nefecon and Busulipo

4 Jan 2012
Antigen Express to move AE37 cancer vaccine into larger clinical trials

Antigen Express to move AE37 cancer vaccine into larger clinical trials

4 Jan 2012
BioMarin to initiate BMN-111 Phase 1 trial in achondroplasia

BioMarin to initiate BMN-111 Phase 1 trial in achondroplasia

4 Jan 2012
BioLineRx commences BCM CE Mark registration trial for prevention of cardiac remodeling following AMI

BioLineRx commences BCM CE Mark registration trial for prevention of cardiac remodeling following AMI

4 Jan 2012
Arena, Eisai collaborate in response to FDA's lorcaserin Complete Response Letter

Arena, Eisai collaborate in response to FDA's lorcaserin Complete Response Letter

4 Jan 2012
Yakult Honsha commences perifosine Phase 1/2 trial for refractory advanced colorectal cancer in Japan

Yakult Honsha commences perifosine Phase 1/2 trial for refractory advanced colorectal cancer in Japan

4 Jan 2012
Positive results from Can-Fite BioPharma's CF102 Phase 1/2 study on HCC

Positive results from Can-Fite BioPharma's CF102 Phase 1/2 study on HCC

4 Jan 2012
Ampio completes enrollment phase of Australian Ampion In Knee trials

Ampio completes enrollment phase of Australian Ampion In Knee trials

3 Jan 2012
Astellas, AVEO announce results of tivozanib and sorafenib comparison trial on RCC

Astellas, AVEO announce results of tivozanib and sorafenib comparison trial on RCC

3 Jan 2012
Additional financing to fund Advaxis' cervical cancer trials

Additional financing to fund Advaxis' cervical cancer trials

31 Dec 2011
FDA invites Amgen for ODAC meeting on XGEVA sBLA to treat castration-resistant prostate cancer

FDA invites Amgen for ODAC meeting on XGEVA sBLA to treat castration-resistant prostate cancer

30 Dec 2011
GOG targeted therapy phase 3 clinical trial delays progression of advanced ovarian cancer

GOG targeted therapy phase 3 clinical trial delays progression of advanced ovarian cancer

29 Dec 2011
Bevacizumab delays disease progression in ovarian cancer

Bevacizumab delays disease progression in ovarian cancer

29 Dec 2011
Emergent commences Phase 2 combination trial of TRUw-016 with bendamustine in relapsed CLL

Emergent commences Phase 2 combination trial of TRUw-016 with bendamustine in relapsed CLL

29 Dec 2011
Critical considerations for adenovirus-based HIV vaccine trials

Critical considerations for adenovirus-based HIV vaccine trials

28 Dec 2011
IL-1 gene inactivation may reduce severe clinical complications of atherosclerosis

IL-1 gene inactivation may reduce severe clinical complications of atherosclerosis

28 Dec 2011
CEL-SCI to expand Multikine Phase III trial in head and neck cancer

CEL-SCI to expand Multikine Phase III trial in head and neck cancer

27 Dec 2011
Initial results from 22nd Century's X-22 Phase II-B smoking cessation trial

Initial results from 22nd Century's X-22 Phase II-B smoking cessation trial

26 Dec 2011
Correcting anemia can preserve kidney function in many transplant recipients

Correcting anemia can preserve kidney function in many transplant recipients

23 Dec 2011
Top-line results from Noven's LDMP Phase 3 clinical study on menopausal VMS

Top-line results from Noven's LDMP Phase 3 clinical study on menopausal VMS

23 Dec 2011

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback